Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C22H34ClN3O2 |
| Molecular Weight | 407.977 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)N(CCC(CCN1CCCCC1)(C(N)=O)C2=CC=CC=C2Cl)C(C)=O
InChI
InChIKey=GTEPPJFJSNSNIH-UHFFFAOYSA-N
InChI=1S/C22H34ClN3O2/c1-17(2)26(18(3)27)16-12-22(21(24)28,19-9-5-6-10-20(19)23)11-15-25-13-7-4-8-14-25/h5-6,9-10,17H,4,7-8,11-16H2,1-3H3,(H2,24,28)
| Molecular Formula | C22H34ClN3O2 |
| Molecular Weight | 407.977 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Electrophysiologic effects of an antiarrhythmic agent, bidisomide, on sodium current in isolated rat ventricular myocytes: comparison with mexiletine and disopyramide. | 2001-05 |
|
| Mechanism of compound- and species-specific food effects of structurally related antiarrhythmic drugs, disopyramide and bidisomide. | 1998-03 |
|
| Reduced systemic availability of an antiarrhythmic drug, bidisomide, with meal co-administration: relationship with region-dependent intestinal absorption. | 1998-02 |
|
| Metabolism of a novel antiarrhythmic agent, bidisomide, in man: use of high resolution mass spectrometry to distinguish desisopropyl bidisomide from desacetyl bidisomide. | 1995-09 |
|
| Bidisomide (SC-40230), a new antiarrhythmic agent: initial study of tolerability and pharmacokinetics. | 1992-04 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1563207
Intravenous doses ranged from 0.03 to 2.5 mg/kg.
Route of Administration:
Intravenous
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:18:39 GMT 2025
by
admin
on
Mon Mar 31 19:18:39 GMT 2025
|
| Record UNII |
2X3Z153A4O
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
116078-65-0
Created by
admin on Mon Mar 31 19:18:39 GMT 2025 , Edited by admin on Mon Mar 31 19:18:39 GMT 2025
|
PRIMARY | |||
|
6598
Created by
admin on Mon Mar 31 19:18:39 GMT 2025 , Edited by admin on Mon Mar 31 19:18:39 GMT 2025
|
PRIMARY | |||
|
m2478
Created by
admin on Mon Mar 31 19:18:39 GMT 2025 , Edited by admin on Mon Mar 31 19:18:39 GMT 2025
|
PRIMARY | Merck Index | ||
|
368
Created by
admin on Mon Mar 31 19:18:39 GMT 2025 , Edited by admin on Mon Mar 31 19:18:39 GMT 2025
|
PRIMARY | |||
|
SUB05824MIG
Created by
admin on Mon Mar 31 19:18:39 GMT 2025 , Edited by admin on Mon Mar 31 19:18:39 GMT 2025
|
PRIMARY | |||
|
DTXSID60869599
Created by
admin on Mon Mar 31 19:18:39 GMT 2025 , Edited by admin on Mon Mar 31 19:18:39 GMT 2025
|
PRIMARY | |||
|
100000085901
Created by
admin on Mon Mar 31 19:18:39 GMT 2025 , Edited by admin on Mon Mar 31 19:18:39 GMT 2025
|
PRIMARY | |||
|
2X3Z153A4O
Created by
admin on Mon Mar 31 19:18:39 GMT 2025 , Edited by admin on Mon Mar 31 19:18:39 GMT 2025
|
PRIMARY | |||
|
C166602
Created by
admin on Mon Mar 31 19:18:39 GMT 2025 , Edited by admin on Mon Mar 31 19:18:39 GMT 2025
|
PRIMARY | |||
|
CHEMBL305745
Created by
admin on Mon Mar 31 19:18:39 GMT 2025 , Edited by admin on Mon Mar 31 19:18:39 GMT 2025
|
PRIMARY | |||
|
BB-70
Created by
admin on Mon Mar 31 19:18:39 GMT 2025 , Edited by admin on Mon Mar 31 19:18:39 GMT 2025
|
PRIMARY | |||
|
59798
Created by
admin on Mon Mar 31 19:18:39 GMT 2025 , Edited by admin on Mon Mar 31 19:18:39 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |